DLB vs. UTHR
DLB (Dolby Laboratories, Inc.) and UTHR (United Therapeutics Corporation) are both stocks. DLB operates in Information Technology Services (Technology), while UTHR operates in Biotechnology (Healthcare). Over the past 10 years, DLB returned 3.25%/yr vs 15.19%/yr for UTHR. Their 0.24 correlation means their historical movements had little consistent relationship.
Performance
DLB vs. UTHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DLB achieves a -7.35% return, which is significantly lower than UTHR's 6.25% return. Over the past 10 years, DLB has underperformed UTHR with an annualized return of 3.25%, while UTHR has yielded a comparatively higher 15.19% annualized return.
DLB
- 1D
- 13.58%
- 1M
- 14.98%
- 6M
- -7.30%
- YTD
- -7.35%
- 1Y
- -14.25%
- 3Y*
- -11.32%
- 5Y*
- -8.13%
- 10Y*
- 3.25%
- ALL TIME*
- 5.82%
UTHR
- 1D
- -1.54%
- 1M
- -6.87%
- 6M
- 10.27%
- YTD
- 6.25%
- 1Y
- 75.92%
- 3Y*
- 29.19%
- 5Y*
- 23.26%
- 10Y*
- 15.19%
- ALL TIME*
- 17.35%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $52.16M | $49.74M | $49.49M | |
| $217.22M | $211.82M | $269.54M |
DLB vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | -7.35% | -16.27% | -7.95% | 23.82% | -24.90% | -0.99% | 42.99% | 12.63% | 0.78% | 38.73% |
UTHR United Therapeutics Corporation | 6.25% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
Correlation
The correlation between DLB and UTHR is -0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.03 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Feb 17, 2005 | 0.24 |
The correlation between DLB and UTHR shifts across timeframes, from -0.03 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
DLB:
$5.59B
UTHR:
$21.98B
DLB:
$2.67
UTHR:
$27.12
DLB:
22.02
UTHR:
19.09
DLB:
32.50
UTHR:
0.63
DLB:
4.16
UTHR:
7.75
DLB:
2.15
UTHR:
4.14
DLB:
$1.35B
UTHR:
$3.17B
DLB:
$1.19B
UTHR:
$2.74B
DLB:
$343.77M
UTHR:
$1.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DLB vs. UTHR — Risk / Return Rank
DLB
UTHR
DLB vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dolby Laboratories, Inc. (DLB) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DLB | UTHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.57 | ||
| Sortino ratioReturn per unit of downside risk | -5.20 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.49 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -0.58 | 6.71 | -7.30 |
| Martin ratioReturn relative to average drawdown | -1.13 | 15.67 | -16.80 |
Loading charts...
Drawdowns
DLB vs. UTHR - Drawdown Comparison
The maximum DLB drawdown since its inception was -62.19%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for DLB and UTHR.
Loading charts...
Drawdown Indicators
| DLB | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.19% | -93.18% | +30.99% |
Max Drawdown (1Y)Largest decline over 1 year | -34.75% | -13.25% | -21.50% |
Max Drawdown (3Y)Largest decline over 3 years | -43.20% | -33.00% | -10.20% |
Max Drawdown (5Y)Largest decline over 5 years | -48.66% | -33.00% | -15.66% |
Max Drawdown (10Y)Largest decline over 10 years | -49.24% | -55.56% | +6.32% |
Current DrawdownCurrent decline from peak | -38.46% | -13.25% | -25.21% |
Average DrawdownAverage peak-to-trough decline | -22.52% | -35.18% | +12.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.03% | 5.66% | +12.37% |
Volatility
DLB vs. UTHR - Volatility Comparison
Dolby Laboratories, Inc. (DLB) has a higher volatility of 15.09% compared to United Therapeutics Corporation (UTHR) at 6.09%. This indicates that DLB's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DLB | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.09% | 6.09% | +9.00% |
Volatility (6M)Calculated over the trailing 6-month period | 25.35% | 25.86% | -0.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.68% | 47.15% | -17.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.97% | 35.05% | -9.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.03% | 34.89% | -7.86% |
Dividends
DLB vs. UTHR - Dividend Comparison
DLB's dividend yield for the trailing twelve months is around 2.40%, while UTHR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DLB Dolby Laboratories, Inc. | 2.40% | 2.10% | 1.57% | 1.29% | 1.45% | 0.96% | 0.91% | 1.15% | 1.08% | 0.94% | 1.11% | 1.25% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
DLB vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between Dolby Laboratories, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DLB vs. UTHR - Profitability Comparison
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Dolby Laboratories, Inc. reported a gross profit of 264.68M and revenue of 305.00M. Therefore, the gross margin over that period was 86.8%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Dolby Laboratories, Inc. reported an operating income of 34.32M and revenue of 305.00M, resulting in an operating margin of 11.3%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Dolby Laboratories, Inc. reported a net income of 58.39M and revenue of 305.00M, resulting in a net margin of 19.1%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
Frequently Asked Questions
DLB and UTHR have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DLB has higher volatility (15.09%) compared to UTHR (6.09%). In terms of maximum drawdown, DLB dropped -62.19% vs UTHR's -93.18%.
UTHR currently has the higher Sharpe Ratio (1.89 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DLB and UTHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer